Crossmark

Risks of Myocarditis and Pericarditis Following Vaccination with SARS-CoV-2 mRNA Vaccines in Japan: An Analysis of Spontaneous Reports of Suspected Adverse Events

Crossref DOI link: https://doi.org/10.1007/s43441-022-00466-1

Published Online: 2022-10-30

Published Print: 2023-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kobayashi, Hidetaka https://orcid.org/0000-0002-8889-7144
Fukuda, Sayoko

Matsukawa, Rina

Asakura, Yumi

Kanno, Yuri

Hatta, Tomohiro

Saito, Yurina

Shimizu, Yuki

Kawarasaki, Shuichi

Kihara, Mari

Kinoshita, Natsumi

Umeda, Hikari

Noda, Tatsuya

Imamura, Tomoaki

Nishioka, Yuichi

Yamaguchi, Toshihiro

Hayashi, Shuichiro

Iguchi, Toyotaka
License Information

Text and Data Mining valid from 2022-10-30

Version of Record valid from 2022-10-30
More Information

Article History

Received: 16 May 2022

Accepted: 30 September 2022

First Online: 30 October 2022

Declarations

:

: All authors declared no competing interests.

: Not applicable in waiver of the ethics committee of PMDA, approved by the Ethics Committee of Nara Medical University (No. 2831. 2020/10/30).

: The views expressed in the discussion part of this article are those of the authors and do not necessarily reflect the official views of Pharmaceuticals and Medical Devices Agency.

: All authors declare to consent to participate in the research.

: All authors declare to consent the publication of the article.

Free to read: This content has been made available to all.

Document is current

Any future updates will be listed below